You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 5, March 9, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Oncology, Other
 •Patient-Physician Communication
 •End-of-life Care/ Palliative Medicine
 •Quality of Care
 •Quality of Care, Other
 •Quality of Life
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Health Care Costs in the Last Week of Life

Associations With End-of-Life Conversations

Baohui Zhang, MS; Alexi A. Wright, MD; Haiden A. Huskamp, PhD; Matthew E. Nilsson, BS; Matthew L. Maciejewski, PhD; Craig C. Earle, MD; Susan D. Block, MD; Paul K. Maciejewski, PhD; Holly G. Prigerson, PhD

Arch Intern Med. 2009;169(5):480-488.

Background  Life-sustaining medical care of patients with advanced cancer at the end of life (EOL) is costly. Patient-physician discussions about EOL wishes are associated with lower rates of intensive interventions.

Methods  Funded by the National Institute of Mental Health and the National Cancer Institute, Coping With Cancer is a longitudinal multi-institutional study of 627 patients with advanced cancer. Patients were interviewed at baseline and were followed up through death. Costs for intensive care unit and hospital stays, hospice care, and life-sustaining procedures (eg, mechanical ventilator use and resuscitation) received in the last week of life were aggregated. Generalized linear models were applied to test for cost differences in EOL care. Propensity score matching was used to reduce selection biases.

Results  Of 603 participants, 188 (31.2%) reported EOL discussions at baseline. After propensity score matching, the remaining 415 patients did not differ in sociodemographic characteristics, recruitment sites, illness acknowledgment, or treatment preferences. Further analyses, adjusted by quintiles of propensity scores and significant confounders, revealed that the mean (SE) aggregate costs of care (in 2008 US dollars) were $1876 ($177) for patients who reported EOL discussions compared with $2917 ($285) for patients who did not, a cost difference of $1041 (35.7% lower among patients who reported EOL discussions) (P =.002). Patients with higher costs had worse quality of death in their final week (Pearson production moment correlation partial r = –0.17, P =.006).

Conclusions  Patients with advanced cancer who reported having EOL conversations with physicians had significantly lower health care costs in their final week of life. Higher costs were associated with worse quality of death.


Author Affiliations: Center for Psycho-Oncology and Palliative Care Research (Ms Zhang, Mr Nilsson, and Drs Block and Prigerson) and Departments of Medical Oncology (Drs Wright and Earle) and Population Sciences (Dr Earle), Dana-Farber Cancer Institute, Department of Health Care Policy (Dr Huskamp) and Center for Palliative Care (Drs Block and Prigerson), Harvard Medical School, and Department of Psychiatry, Brigham and Women's Hospital (Drs Block and Prigerson), Boston, Massachusetts; Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, and Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill (Dr M. L. Maciejewski); and Department of Psychiatry, Women's Health Research, and Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, Connecticut (Dr P. K. Maciejewski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Life Prolonging in Name Only?—Reply
Holly G. Prigerson, Alexi A. Wright, Paul K. Maciejewski, and Susan D. Block
Arch Intern Med. 2009;169(16):1540-1541.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Open Letter to President Obama on Health Care Reform
Hammer et al.
Am J Crit Care 2009;18:512-513.
FULL TEXT  

Life Prolonging in Name Only?
Workman
Arch Intern Med 2009;169:1540-1540.
FULL TEXT  

Preferences for dialysis withdrawal and engagement in advance care planning within a diverse sample of dialysis patients
Kurella Tamura et al.
Nephrol Dial Transplant 2009;0:gfp430v2-gfp430.
ABSTRACT | FULL TEXT  

Opportunities To Improve The Quality Of Care For Advanced Illness
Krakauer et al.
Health Aff (Millwood) 2009;28:1357-1359.
ABSTRACT | FULL TEXT  

Making Difficult Discussions Easier: Using Prognosis to Facilitate Transitions to Hospice
Finlay and Casarett
CA Cancer J Clin 2009;59:250-263.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.